Ravi Anupindi, professor of technology and operations at the University of Michigan Ross School of Business, discusses how vaccine supply chains are faring with unprecedented stresses, and what it might mean for the distribution of coronavirus vaccines as promising progress is reported. He asks "With global constrained supply and weak purchasing power, will these countries get sufficient vaccines to cover at least essential workers? More broadly, the world needs to consider what “a fair and equitable allocation” means if we assume that every life has equal value." Read the story.
